ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
84.50
+1.22 (1.46%)
At close: Jun 26, 2026, 4:00 PM EDT
85.00
+0.50 (0.59%)
After-hours: Jun 26, 2026, 7:18 PM EDT
ANI Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ANI Pharmaceuticals stock have an average target of 115.2, with a low estimate of 100 and a high estimate of 124. The average target predicts an increase of 36.33% from the current stock price of 84.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 20, 2026.
Analyst Ratings
The average analyst rating for ANI Pharmaceuticals stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $100 | Buy | Maintains | $100 | +18.34% | May 20, 2026 |
| Truist Financial | Truist Financial | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 11, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $124 | Buy | Reiterates | $124 | +46.75% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $121 | Buy | Reiterates | $121 | +43.20% | May 8, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 8, 2026 |
Financial Forecast
Revenue This Year
1.12B
from 883.37M
Increased by 26.47%
Revenue Next Year
1.24B
from 1.12B
Increased by 11.34%
EPS This Year
9.37
from 7.89
Increased by 18.72%
EPS Next Year
10.69
from 9.37
Increased by 14.18%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1B | 1.4B | |
| Avg | 1.1B | 1.2B | |
| Low | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.4% | 21.9% | |
| Avg | 26.5% | 11.3% | |
| Low | 25.3% | 4.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.60 | 13.06 | |
| Avg | 9.37 | 10.69 | |
| Low | 9.19 | 9.48 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.7% | 39.4% | |
| Avg | 18.7% | 14.2% | |
| Low | 16.5% | 1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.